CRSP logo

ARKG Holdings of CRSP

CRISPR Therapeutics

CRISPR Therapeutics is a biotechnology company focused on developing gene-editing therapies using CRISPR/Cas9 technology to treat various genetic diseases. The company generates revenue through partnerships, licensing agreements, and potentially through the commercialization of its therapeutic products once they receive regulatory approval.

Trades of CRSP in ARKG

The ten most recent trades of CRISPR Therapeutics in the ARKG ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Jan 17, 2025Buy$890,9301.18%0.08%
Jan 17, 2025Buy$890,9301.18%0.08%
Jan 17, 2025Buy$890,9301.18%0.08%
Jan 16, 2025Buy$795,3111.09%0.07%
Dec 27, 2024Buy$576,6490.79%0.05%
Dec 24, 2024Buy$203,3710.28%0.02%
Dec 13, 2024Buy$1,115,6861.43%0.10%
Nov 19, 2024Buy$112,4850.14%0.01%
Nov 18, 2024Buy$566,9000.68%0.05%
Nov 15, 2024Buy$280,7620.34%0.02%